Advanced ICU Care®, the nation’s largest provider of tele-ICU services, has announced 60 percent growth in the number of ICU beds monitored in 2013, indicating the value of the solution. The company’s continued growth demonstrates the increasing need for tele-ICU support as a result of a rapidly aging population, shortage of ICU intensivists and staff, and the need to achieve strong clinical outcomes.
IntelliCyt Corporation, a provider of assay screening solutions for phenotypic drug discovery, antibody discovery and in vitro toxicity testing, today announced the MultiCyt™ QBeads PlexScreen family of reagents. It is the first commercially available product to enable multiplexed analysis of secreted proteins at the pace and price needed for screening and the latest addition to IntelliCyt’s platform of instrumentation, application-specific reagents, integrated multi-user analysis and informatics tools. MultiCyt™ QBeads will be featured at the Society for Laboratory Automation and Screening conference (SLAS2014) in San Diego next week.
PLYMOUTH, Mich.–(BUSINESS WIRE)– Esperion Therapeutics, Inc. (Nasdaq: ESPR), a clinical-stage biopharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol (LDL-C) lowering therapies for the treatment of hypercholesterolemia, announced the appointment of Antonio M. Gotto Jr., M.D., DPhil as a Director of the Company. Dr. Gotto will serve as a Class II director with a term of office expiring at our 2015 annual meeting of stockholders.
ISTO Technologies, Inc., a privately-held orthobiological regenerative medicine company, announced today that George W. Dunbar, Jr., a well-recognized senior executive with over 25 years’ experience in the field of life sciences, was appointed President and Chief Executive Officer, effective immediately.
Deerfield Management Company has just announced that it has entered into a secured loan facility with Fidelis SeniorCare, Inc. for up to $50.0 million in financing.
Delphinus Medical Technologies, Inc., innovator and developer of a new ultrasound platform that images the entire breast, has received 510(k) clearance from the U.S. Food and Drug Administration for the SoftVue™ whole breast ultrasound tomography system, approved for diagnostic breast imaging.